Home
Relypsa

Relypsa Market Share Analysis for May 2026

csl vifor us is a biopharmaceutical leader driven by its promise to save and improve lives. we manufacture remedies for rare and serious conditions.

Science and Education > Chemistry

Domainrelypsa.com

Year Founded1994

Employees201 - 500

Annual Revenue$15M - $25M

Relypsa

Relypsa (including company regionals)

relypsa.com

See more website traffic and engagement information

Relypsa Revenue up to May 2026 is 15M - 25M

revenue generated by Relypsa top domains

Relypsa top domains revenue over 3 years

Revenue for Relypsa top domains

relypsa.com15M - 25M

See more with Sales Intelligence

Total visits to Relypsa's top domains

Understand Relypsa market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Relypsa's top domains

Analyze Relypsa engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Relypsa's top domains

See how Relypsa keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Relypsa top competitors by domain

Top similar sites in May 2026, ranked by their affinity

binghamtonsa.orgCompany NameStudent Association At Binghamton Uni...Employees51 - 200HQUnited States, New York, VestalAnnual revenue$2M - $5MTotal visits3.5KScience and Education > Universities and Colleges

Top technologies used by Relypsa

These are the website technologies, by industry, used by Relypsa top domains

Widget (3)

reCAPTCHA

Audio Video Media (2)

YouTube

Content Management System (2)

Drupal

Payment & Currencies (2)

Pound Sterling

More Technologies

9

See all

News & Signals from Relypsa

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsRelypsa, Inc. hired Patrick Treanor as president on May 1st '15.Relypsa, Inc., a Vifor Pharma Group company, today announced the appointment of Patrick Treanor as president on an interim basis, effective October 1, 2018.

NewsVifor Pharma acquired Relypsa, Inc. on Jan 1st '16.During his tenure, Mr. Garland was responsible for the integration and growth of the U.S. operations after Relypsa was acquired by Vifor Pharma Group in 2016.

NewsGarland leaves Relypsa, Inc. as president and previously chief commercial officer.Mr. Garland joins Portola from Relypsa, Inc., where he was President and previously Chief Commercial Officer.